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INTRODUCTION 
 We are concerned about the wound healing in post operative patients, 
since wound complications will increase the morbidity of patient. Wound 
management is a basic practice in surgery, especially after an elective 
abdominal surgery. Our task after surgery is to avoid and thereby to reduce the 
adverse effects of wound complications. Wound seromas, hematomas and 
surgical site infections are the most common complications. Obese patients are 
at risk for the local wound complications. A number of methods have been 
used by us from time to time to reduce these complications. Use of 
subcutaneous drain in surgical wounds is one among them. The rationale for 
the use of subcutaneous drain is based on the principle that removal of the 
collecting serum or debris and elimination of dead space in subcutaneous plane 
will result in lower rate of infection and wound complications. Only a few 
studies are available in the literature regarding the role of subcutaneous drain in 
the prevention of local wound complications and majority of these studies were 
done in female patients who undergo gynaecological or breast surgeries, with 
controversial results. Many elective abdominal surgeries are routinely 
performed in general surgical units of our institution and a subcutaneous 
collection in such patients increases the morbidity. 
 
 
 
  
OBJECTIVES 
                  The main objective of our study is to determine whether 
subcutaneous drain can reduce the post operative wound complications in 
obese patients undergoing elective abdominal surgery in the Department of 
General Surgery at Coimbatore medical college hospital. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
LAYERS OF THE ABDOMINAL WALL: 
 The layers of the abdominal wall includes the following
 
1) Skin 
2) Subcutaneous tissue having superficial fatty Camper fascia and deep 
Scarpa fascial layer 
3) External oblique aponeurosis and associated ligaments                                                           
4) Internal oblique and  Transverse abdominis muscles  
5) Rectus abdominis and rectus sheath
24
 
The lines of cleavage in the skin will be horizontally placed around the 
trunk and the incisions can be planned accordingly. Subcutaneous layer is 
composed of adipocytes, blood vessels and lymphatics. Camper fascia is the 
  
superficial fatty layer which lies below the skin and that layer will be 
continuous with the outer fascial layers covering the perineum. This layer also 
contains the dartos muscle fibres of the scrotum. The lymphatics traversing this 
layer will be draining to the axillary nodes above and inguinal nodes below. 
The superficial epigastric, superficial external pudendal and superficial 
circumflex iliac vessels run in the Campers fascia. 
         Scarpa fascia is the second layer made up of compressed fibrous 
elements. This forms the suspensory ligament of the penis or clitoris. It fuses 
with the membranous layer of the superficial fascia, the Colles fascia in the 
perineum. 
    Cutaneous nerve supply to the anterior abdominal wall is derived from 
the anterior rami of the lower six thoracic and first lumbar nerves. These nerves 
reach the abdominal wall by piercing the rectus sheath
27
. 
MUSCLES, LIGAMENTS AND APONEUROSIS 
 Muscles arranged from exterior to interior are the external oblique, 
internal oblique and tranversus abdominis. On either side of the midline are the 
rectus abdominis muscles. The linea alba is the midline intersection of the three 
aponeurosis. Pyramidalis is a small muscle in the lower part of the rectus 
sheath. Cremaster muscle derived from the internal oblique covers the 
spermatic cord. 
 
  
 
 
 
 
 
EXTERNAL OBLIQUE MUSCLE AND ASSOCIATED 
LIGAMENTS  
The muscle fibre
eight ribs. These muscle fibres
the middle and lower parts. They get inserted into the xiphoid process, linea 
alba, pubic crest, pubic tubercle and anterior half of the iliac crest. The 
lowermost fibres get folded upon themselves to form the inguinal ligament.
The posterior most fibres along with iliac cres
dorsi forms the inferior lumbar triangle of Petit.
the medial and lateral crus of the superficial inguinal ring. The sper
or the round ligament
genitofemoral nerve pass through this opening. Ext
from these crural margins.  The inguinal ligament forms the superior pubic 
 
s take origin from the posterior aspect of the lower
 run horizontally in its upper part and oblique in 
t and anterior fibres of lattissimus 
 The medial most fibres form 
, ilioinguinal nerve and the genital branch of the 
ernal spermatic fascia arises 
 
 
matic cord 
  
ligaments by fusing with the anterior rectus sheath and opposite inguinal 
ligament. Gimbernat’s ligament is formed by downward continuation of the 
inguinal ligament to the superior pubic ramus
30
. The lateral extension of the 
inguinal ligament forms the Pectineal ligament of Cooper. 
INTERNAL OBLIQUE AND TRANVERSUS MUSCLES AND 
APONEUROSIS 
Internal oblique arises from the lumbar fascia, anterior two-thirds of the 
iliac crest and the lateral two-thirds of the inguinal ligament. The fibres get 
inserted into the lower three ribs and their costal cartilages, xiphoid process, 
linea alba and pubic symphysis. The transversus abdominis muscle arises from 
the lower six costal cartilages, lumbar fascia, anterior two-thirds of the iliac 
crest and lateral third of the inguinal ligament
31
. The fibres of the transverses 
abdominis contributes to the rectus sheath and forms the falx inguinalis. 
Transversalis fascia otherwise known as the endoabdominal fascia that covers 
the internal surface of the transversus abdominis muscle, iliacus, psoas muscles 
and the obturator internus muscles. 
  
 
RECTUS ABDOMINIS AND RECTUS SHEATH 
 This muscle arises from the pubic symphysis, pubic crest and gets 
inserted into the fifth, sixth and seventh costal cartilages and xiphoid process. 
Rectus sheath is a long fibrous sheath that encloses the rectus abdominis 
muscle
33
. Between the umbilicus and the pubis, rectus sheath does not have the 
posterior wall and the anterior wall is formed by the aponeurosis of all the three 
muscles. The arcuate line is the curved free border of the posterior wall which 
allows for the free passage of the deep inferior epigastric vessels into the rectus 
sheath
29-34
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ANTISEPSIS AND ASEPSIS 
Without proper antisepsis and asepsis, the major surgeries would end in 
severe complications. Joseph Lister (1827-1912) has done monumental efforts 
to introduce the systematic, scientifically based antisepsis in the treatment of 
wounds and the performance of surgical operations. It was clearly evident for 
him that excessive heat could not be applied for the surgical patient. So he used 
chemical asepsis such as carbolic acid onto wounds and dressings. Lister used 
carbolic acid spray around the operating field and table. He did not emphasize 
the importance of hand scrubbings as he believed that scrubbing hands created 
crevices in the palm which can harbor bacteria and cause infection. He also 
made advancements by introducing the sterile absorbable sutures such as 
carbolic catgut sutures. All his ideas were poorly perceived because of 
complexity, time consuming and many surgeons unable to replicate the results 
of Lister. The use of autoclave has been promoted for sterilizing the 
instruments. Thus the concept of drains to avoid collection in the surgical 
wounds came into evolution
8
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WOUND HEALING 
  DEFINITION – It is a process of restoring anatomical and physiological 
integrity of damaged tissues by several blood cells such as polymorphs, 
monocytes, macrophage and fibroblasts in an organized manner. 
TYPES OF WOUND HEALING 
   Primary healing- It is healing by first intention. Occurs in clean 
wounds. The edges of the wound are approximated with sutures or staplers, 
there is more regeneration of epithelium near the edges rather than fibrosis. It 
will result in a linear smooth scar. 
  Secondary healing - It is healing by second intention. Wounds with 
extensive tissue loss such as those seen in trauma, burns tend to heal by 
secondary intention. Wound heals by fibrosis. This ends in a wide, 
hypertrophied scar. This results in a contracted scar thereby it may lead into 
disability. 
     Tertiary healing - It is healing by third intention or by delayed primary 
closure. After removing the devitalized tissues wound is closed with loose 
stitches
19
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STAGES OF WOUND HEALING 
→ Stage of inflammation 
→ Stage of granulation tissue formation. 
→ Stage of epithelialization. 
→ Stage of scar formation and resorption 
→ Stage of maturation. 
PHASES OF WOUND HEALING 
INFLAMMATORY PHASE 
 It is a lag phase or exudative phase. It begins immediately after the 
injury and lasts for 72 hours. It comprises of coagulation and chemotaxis. 
Initially there will be vasospasm and thrombus formation and later on there will 
be vasodilation. The five cardinal features of inflammation are rubor, calor, 
tumor, dolor and loss of function. Chemotaxis and release of inflammatory 
mediators are suppressed in diabetes mellitus and in other 
immunocompromised states
19
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PROLIFERATIVE PHASE 
  It is otherwise known as collagen or fibroblastic phase. It begins from 
3
rd
 day and last for 3-6 weeks, This phase is composed of granulation tissue 
formation. Granulation tissue is made of fibroblast, capillaries, collagen and 
fibronectin. VEGF is responsible for angiogenesis. Fibroblast proliferation and 
type 3 collagen leads to fibroplasia. The basal layer of epidermis migrates to 
the surface and proliferates, differentiate and stratifies to promote wound 
closure. 
 
 
 
 
 
 
REMODELING PHASE  
              It is also known as the maturation phase. It starts at 6 weeks and last 
upto 1 year. The tensile strength of the scar is due to the maturation of 
collagen, because of the cross linking and alignment of the collagen fibres 
along the line of tension. Contraction of the wound is due to the myofibroblast. 
  
Maturation of the collagen is due to type 1 collagen. Granulation tissue consists 
of type 3 collagen. Final scar and the extracellular matrix contains type 1 
collagen. Final matured scar is avascular and acellular. Normal skin contains 
predominantly type 1 collagen. Collagen production reduces after 4 weeks of 
wound healing. B Lymphocytes has no role in wound healing. A normally 
healed wound gains 50% of the tensile strength after 6 weeks
19
.  
 
  
 
 
 
 
SURGICAL COMPLICATIONS 
 Surgical complications always remain a frustrating and difficult part to 
treat. Regardless of how technically gifted and capable surgeons are, everyone 
has to deal with the complications that occur after the surgical procedures. 
These complications occur because of variety of reasons. It could be due to the 
patient’s condition already compromised by the disease process, technical 
errors in the surgical procedures or finally complications can arise because of 
the nature of disease. These complications can be prevented to certain extent by 
  
taking proper precautions. Proper assessment of the patients such as cardiac 
status, health of the lungs and nutritional status should be properly assessed. 
Timing of the procedure whether performed electively or as an emergency 
procedure also plays an important aspect as far as the surgical complications 
are concerned. The status of the patient whether the patients can withstand the 
stress of the procedure such as cardiac status or the status of the lungs will be 
required. Obese patients have to lose their body weight before performing 
certain procedures to make the procedures successful. Technical aspects such 
as handling tissues gently, dissecting meticulously and honoring the tissue 
planes are always important in reducing the surgical wound complications. 
Preoperative use of antibiotics also influences the outcome in certain patients. 
Once the procedure is completed, proper postoperative surveillance is 
mandatory to identify the complications at an early stage and to treat it 
accordingly. This surveillance includes inspection of all the wounds, evaluation 
of temperature, pulse rate and intake and output charts, evaluation of patients 
performance status and also the incidence of pain after the procedure. 
SURGICAL WOUND COMPLICATIONS 
SEROMA  
 A seroma can be defined as the collection of liquefied fat, serum or the 
lymphatic fluid under the incision. The collection will be mostly clear, yellow 
or viscous and will be present in the subcutaneous layer of the skin. This is a 
known complication which most commonly occurs after raising large skin flaps 
  
in procedures such as mastectomy, axillary dissection, groin dissection or large 
ventral hernias or when a prosthetic mesh such as polytetrafluoroethylene mesh 
used in the repair of ventral hernias. 
 It could manifest as a localized swelling causing discomfort or 
sometimes the discharge of clear liquid from the immature wound. Prevention 
of this seroma can be done by placing suction drains under the flaps.  It can be 
aspirated under sterile precautions and followed by pressure dressing.  If 
seroma reaccumulates after two aspirations, then it should be evacuated by 
opening the incision and packing the wound with saline moistened gauze to 
allow for healing to occur by secondary intention.  If seroma occurs after 
placing synthetic mesh, then it should be drained only in operating room and it 
should be again closed in layers with a suction drain. In case of spreading 
cellulitis or active sepsis, any synthetic mesh should be removed
5
. 
HEMATOMA 
 A hematoma can be defined as the abnormal collection of blood that 
occurs in the subcutaneous layer of a recent incision or in a potential space in 
the abdominal cavity after extirpation of an organ, for example splenic 
hematoma after splenectomy or the pelvic hematoma after proctectomy. 
Hematomas are more prone for secondary infection. The causes for this include 
inadequate hemostasis, depletion of clotting factors or the presence of 
coagulopathy. The diseases which can contribute to coagulopathy include 
myeloproliferative disorders, liver diseases, renal failure, sepsis, clotting factor 
  
deficiencies and medications. Drugs that can cause coagulopathy includes 
antiplatelet agents such as aspirin, clopidogrel, ticlopidine, eptifibatide, 
abciximab and anticoagulants such as unfractionated heparin, low molecular 
weight heparin such as enoxaparin, dalteparin sodium or tinzaparin and vitamin 
k antagonist such as warfarin sodium. 
 It can present as an expanding unsightly swelling or sometimes pain in 
the area of surgical incision. The area where hematoma accumulates produce 
the symptoms such as airway compromise in case of neck hematoma, paralytic 
ileus in case of retroperitoneal hematoma or abdominal compartment syndrome 
in case of abdominal cavity. Hematoma can be visualized as a localized soft 
swelling with purplish blue discoloration of the overlying skin. It can present 
with tenderness on palpation or sometimes with the drainage of dark red fluid 
out through the fresh wound. 
 Hematoma formation can be prevented with preoperative correction of 
clotting factor abnormalities and also discontinuing the drugs that can alter the 
coagulation pathways. Antiplatelets, anticoagulants or vitamin K antagonists 
given for conditions like coronary artery disease, stroke or valve surgeries 
should be stopped temporarily before surgery. The risk of bleeding depends 
upon the type of surgery and the indications for thrombolytic therapy. Patients 
on vitamin K antagonists such as warfarin sodium should be stopped five days 
before surgery to bring the INR value below 1.5. Patients on unfractionated 
heparin whose half-life is 45 minutes should be stopped four hours before 
surgery. Patients on low molecular weight heparin whose half-life is 16-24 
  
hours, should be stopped a day prior to the procedure. In patients undergoing 
major surgery with very high risk for bleeding the initiation of the heparin can 
be delayed for two or three days. Patients on clopidogrel should have stopped 
the drug atleast seven days before the surgery or the procedure can be delayed 
till the completion of the treatment. Antiplatelet therapy can be resumed within 
24 hours after the surgery. In patients with bare metal stent who require surgery 
within six weeks of stent placement, aspirin and clopidogrel should be 
continued in the perioperative period. Patients on warfarin who require urgent 
surgery can be reversed with fresh frozen plasma or prothrombin concentrate 
transfusion, vitamin K administration. Also during surgery bleeding can be 
arrested with ligature, electrocautery, fibrin glue or topical bovine thrombin 
before closure. Closed suction drains placed in large potential spaces should be 
removed postoperatively when the output is not bloody and scant. 
Retroperitoneal hematomas can be managed with correction of coagulopathy or 
evacuation of hematomas in operating room
5
. 
ACUTE WOUND FAILURE 
 Acute wound failure or wound dehiscence otherwise known as burst 
abdomen refers to the postoperative separation of the abdominal 
musculoaponeurotic layers. It carries the risk for evisceration, possibility of 
repeat dehiscence, surgical wound infection and incisional hernia formation. 
The incidence of this complication is 1-3% in all the abdominal operations. It 
occurs most often within 7-10 days postoperative period. The factors associated 
with wound dehiscence are the technical error in fascial closure, emergency 
  
surgery, intra-abdominal infection, advanced age, wound infection, hematoma, 
seroma, elevated intra- abdominal pressure, obesity, chronic corticosteroid use, 
previous wound dehiscence, malnutrition, radiation therapy, chemotherapy, 
systemic disease such as uremia or diabetes mellitus. The type of wound 
closure also plays a role in acute wound failure. Continuous closure will be 
worrisome as suture breakage in one area will weaken the entire suture.  
 It may occur without any warning signs and evisceration makes the 
diagnosis obvious. Sometimes the sudden dramatic drainage of a relatively 
large volume of a clear, salmon-colored fluid precedes dehiscence in 25% of 
the patients. Patients can complain of a ripping sensation. Partial dehiscence 
can be detected by probing the wound with a sterile cotton tipped applicator or 
a gloved finger. 
 Acute wound failure can be prevented by paying careful attention to the 
fascial closure such as proper spacing of the suture, adequate depth of bite of 
the fascia, relaxation of the patient during the closure and achieving a tension-
free suture. Interrupted suture is the best choice in high risk patients. One can 
use a synthetic mesh or bioabsorbable tissue scaffold in case of high risk 
candidates
7
. 
  
 
 
 Treatment of wound dehiscence depends on fascial separation, 
evisceration and intra-abdominal pathology. Wound dehiscence in the proximal 
upper part of the wound can be managed conservatively with saline moistened 
gauze and abdominal binder. In the event of evisceration or any signs of 
peritonitis patient should be shifted to the operating room after fluid 
resuscitation. In the operating room thorough laparotomy made to rule out the 
focal sepsis or the factors responsible for wound dehiscence such as 
anastamotic leak.  If the wound is healthy 
 
 then it can be closed primarily. If slough is present then it may require 
debridement and closure with polygalactin or polyglycolic acid mesh.  After 
the proper granulation of the wound, local advancement flaps or skin grafting 
can be used to cover the wound. But the biggest drawback with this is the 
  
occurrence of incisional hernia. If incisional hernia occurs, then subsequent 
removal of the skin graft and permanent prosthesis placement can be done, or 
closure can be done by component separation technique. If closure is done 
under tension then it may lead to repeat dehiscence or intra abdominal 
hypertension. The closure can be done with temporary device (open abdomen 
technique), closed with synthetic or biological mesh or closure can be 
attempted with negative pressure wound therapy. 
The open abdomen technique has the advantage of avoiding intra 
abdominal hypertension, preserves the fascia and mainly facilitates the reaccess 
of the abdominal cavity. Here the wound will heal by secondary intention. It 
will be associated with prolonged healing time, fluid loss, desiccation, 
enterocutaneous fistula formation and more importantly traumatic injury to the 
bowel loop exposed. Temporary closure methods with vacuum pack closure 
will be useful in protecting the abdominal contents and avoids the secondary 
complications associated with the laparotomy. A fenesterated polyethylene 
sheet can be applied which should be non adherent over the bowel omentum. 
Moist surgical gauze with drains placed on top can be placed and iodophore 
impregnated dressing can be applied. Continuous suction under monitoring can 
be applied. The closure can be attempted after seven to ten days. If the closure 
cannot be achieved then it is allowed to granulate and then closed with skin 
grafting.  
 Absorbable synthetic mesh has the advantage of providing wound 
stability and also resistant to infection. But it can lead to fistula or hernia 
  
formation. If non absorbable mesh is used, it can lead to complications such as 
abscess formation, dehiscence, wound sepsis, mesh extrusion, fistula 
formation. Polypropylene, polyester and polytetrafluoroethylene mesh are the 
synthetic non adsorbabale meshes available. Polytetrafluoroethylene mesh is 
nonadherent to the underlying bowel but it is expensive, does not allow 
granulation and it can lead to chronic infections. Bioprosthesis such as acellular 
dermal matrix can be used. It provides mechanical support to the wound and it 
acts as tissue scaffolding for the tissue ingrowth. These bioprosthesis stimulates 
cellular attachment, migration, new blood vessels formation, repopulation of 
the implanted graft and also reduces the long term complications. There are 
two types of bioprosthesis. These are animal derived such as porcine intestinal 
submucosa, porcine dermis, cross-linked porcine dermal collagen. Human 
derived bioprothesis includes cadaveric human dermis.  
 Negative pressure wound therapy works on the concept of wound 
suction. A vacuum assisted closure device is used often. The device consists of 
a vacuum pump, canister with connecting tubing, open pore foam and 
semiocclusive dressing. It has got many advantages. The advantage includes 
immediate coverage of the wound, acts as the temporary dressing, does not 
require suturing to the fascia, less chance for Intra Abdominal Hypertension 
and prevents the loss of domain. When suction of 125 mm Hg applied to the 
wound, the open-pore foam decreases in size and transmits the negative 
pressure to the surrounding tissue. This leads to the contraction of the wound 
known as macrodeformation. It leads to removal of extra cellular fluid by 
  
decreasing bowel edema, evacuation of excess abdominal fluid and decrease in 
wound size. It stabilizes the wound environment and microdeformation of the 
foam wound interface. These effects will lead to cellular proliferation and 
angiogenesis. It accelerates the wound healing. It reduces the bacterial burden. 
It enhances the wound healing rates. The drawbacks of these devices include 
pain, bleeding, evisceration, hernia formation and formation of enterocutaneous 
fistulas. 
SURGICAL SITE INFECTION (WOUND INFECTION)(SSI): 
HISTORY OF WOUND INFECTION 
 Hippocrates, known as the father of medicine, used vinegar to irrigate 
open wounds and wrapped dressings around wound to prevent further injury. 
His teachings remained unchallenged for centuries. Galen, a roman gladiatorial 
surgeon was the first to recognize that pus from the wounds inflicted by the 
gladiators heralded healing. 
Koch first recognized that the cause of infective foci as secondary to 
microbial growth in his postulates. Joseph Lister and Louis Pasteur 
revolutionized the concept of wound infection. Erichsen, from London 
provided 13 recommendations for the prevention of surgical site infection 
which remains till date. Lister recognized that antisepsis could prevent wound 
infection
20
. 
  
 Surgical site infections are always a major problem and an important 
cause of postoperative morbidity. It is important as it causes significant 
morbidity to the patient and a financial burden to the health care system. If 
uncontrolled it can lead to profound sepsis and death. It constitutes around 40% 
of the hospital acquired infections among surgical patients. The surgical wound 
encompasses the area of the body both internally and externally that involves 
the entire surgical wound. The categories of surgical wound complications are 
as follows: 
1. Superficial that includes skin and subcutaneous tissue 
2. Deep including the fascia and muscle 
3. Organ space that includes the internal organs of the body if the 
operation includes that area. 
          It is believed that the difficulty in obtaining positive culture is related to 
sampling the wrong locations and the notion that bacteria within the bio film 
enter a dormant state due to local nutrient depletion within the bio film. Some 
studies conclude that chronic SSI can arise from underlying bacterial bio film, 
which can invest implanted foreign bodies and associated soft tissue surfaces. 
Surgical site infection is a common surgical complication; culture negative SSI 
presents a big problem in management. Examination of explanted foreign 
bodies (sutures) using confocal laser scanning microscopy and fluorescent 
insitu hybridization after surgical exploration of chronic culture negative SS is 
done. Confocal microscopy demonstrates bacilli and cocci attached to the 
  
explanted sutures in a mixed bio film. Removal of sutures in these occasions 
resolved the infection
22
. 
           The increasing use of minimally invasive surgeries has resulted in a 
decrease in incidence of SSI. The main reasons for the lower incidence of SSI 
in minimally invasive surgeries include smaller incision, earlier mobilization, 
reduction in post operative pain, better preservation of immune system 
functions and decreased use of central venous catheters
10
. 
             Defining an SSI requires evidence of clinical signs and symptoms of 
infection rather than microbiological evidence alone. SSI frequently only affect 
the superficial tissues, but some more serious infections affect the deeper 
tissues or other parts of the body manipulated during the procedure. The 
majority of SSIs become apparent within 30 days of an operative procedure and 
mostly between 5
th
 and 10
th
 post operative days. However, when a prosthetic 
implant is used, SSIs affecting the deeper tissues may occur several months 
after the operation. Although the outcome measure for SSI used by many 
studies is based on standard definitions such as those described by the centers 
for disease control and prevention or surgical site infection surveillance 
service, other valid measures based on clinical signs and symptoms have been 
described such as Southampton and ASEPSIS methods
11
. 
            The Centers for Disease Control and Prevention has proposed the 
following criteria for the diagnosis of surgical site infections. 
 
  
 
 SUPERFICIAL INCISIONAL INFECTION: 
 Infection less than 30 days after surgery that affects skin and 
subcutaneous tissue with purulent discharge or diagnosis of superficial site 
infection by a surgeon or with symptoms of erythema, pain and local edema
12
. 
DEEP INCISIONAL INFECTION: 
 Less than 30 days after surgery with no implant or soft tissue 
involvement or infections occurring in less than one year after surgery with an 
implant or involving deep soft tissues (fascia and muscle) along with purulent 
discharge without involvement of deep organs, abscess found in deep space on 
direct, radiological examination or reoperation, diagnosis of deep space 
infection by a surgeon, symptoms of fever, pain, tenderness leading to 
dehiscence or reopening by a surgeon
12
 
ORGAN SPACE INFECTION:  
 Infection less than 30 days after surgery with no implant or infection 
less than one year after surgery with an implant infection; involves any part of 
the operation opened or manipulated along with purulent discharge through the 
drain placed in organ space, cultured organisms from material aspirated from 
the organ space, abscess found deep or diagnosis of an organ space infection by 
surgeon
13
. 
  These surgical site infections occur mainly because of the contamination 
of the surgical wound with microorganisms. These microorganisms could be 
from endogenous source when th
wall of hollow viscous organ as in the case of enterocutaneous fistulas. The 
exogenous sources could be due to compromise in the sterile surgical 
techniques such as contaminated equipments, implants, gloves or p
techniques from the personnel. The culture 
provide the clue for the source of surgical site infections
 The risk factors for surgical site infections could be 
genetics & genomics of trauma and 
therapy. 
 
 
 
ere occurs a break in skin or a 
of the discharge or the site
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The stress response to injury includes 
   1) Activation of the autonomic nervous system 
   2)  Hypophyseal-pituitary-adrenal axis getting activated 
   3)  Peripheral insulin resistance 
   4)  Production of pro-inflammatory and anti-inflammatory cytokines 
   5)  Production of reactive oxygen species and nitrogen intermediataes 
   6)  Acute phase changes of hepatic protein synthesis 
   7) Recruitment and activation of neutrophils, monocytes, macrophages and 
lymphocytes 
   8) Upregulation of procoagulant activity 
 For the potential pathogens in the environment to invade the normal 
tissue of the body it requires portal of entry such as injured tissue, incision, 
puncture site for vascular access or indwelling catheter. Infection leads to 
repair mechanism that is inflammation which augments the autodestructive 
effects
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. 
 Older age group that is more than 65 years usually leads to adverse 
outcomes following infections.  
 
 
  
The immune dysfunction that occurs after injury includes 
1) Lymphopenia leading to downregulation of T & B lymphocyte 
proliferation, natural killer cell activity, reduced interleukins expression 
2) Monocytosis leading to upregulated acute phase proteins, increased 
inflammatory cytokines production and also elevated eicosanoid 
production 
3) Downregulation of neutrophil production
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HORMONAL RESPONES TO SURGICAL STRESS: 
           Corticotrophin and growth hormones from the anterior pituitary 
increases, arginine vasopressin from the posterior pituitary increased, cortisol 
& aldosterone from the adrenal cortex increases, insulin from the pancreas 
reduced and thyroid hormones getting reduced. 
 The effects of glucose dyshormogenesis during stress and its effect on 
cellular immunity includes the following: 
EFFECTS OF HYPERGLYCEMIA UPON IMMUNE CELL 
FUNCTION 
1) Decreased respiratory burst of alveolar macrophages 
2) Decreased insulin stimulated chemokinesis 
3) Glucose induced protein kinase C activation 
  
4) Increased adherence 
5) Increased adherence molecule generation 
6) Spontaneous activation of neutrophils
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EFFECTS OF STRESS RESPONSE ON CARBOHYDRATE 
METABOLISM 
1) Enhanced peripheral glucose uptake 
2) Hyperlactatemia 
3) Increased gluconeogenesis 
4) Depressed glycogenolysis 
5) Peripheral insulin resistance 
The medical conditions known to increase risk of postoperative infection 
includes
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1) Extremes of ages (neonates or very old adults) 
2) Malnutrition 
3) OBESITY 
4) Diabetes mellitus 
5) Prior site irradiation 
  
6) Hypothermia 
7) Coexisting infection remote to surgical site 
8) Corticosteroid therapy 
9)  Recent operation of chest or abdomen 
10) Chronic inflammation 
11) hypocholesterolemia 
GENETICS AND GENOMICS OF TRAUMA AND SEPSIS: 
 It is always controversial to whether gender influences the host response 
in infection and sepsis. Androgens are immunosuppressive in vitro and animal 
studies. Human data are not confirmatory. As far as genetics are concerned 
single nucleotide polymorphisms or single point mutations of inflammatory 
genes such as Tumor Necrosis Factor alpha, interleukins play a role in 
susceptibility and body’s response to infection
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INTERACTIONS BETWEEN THE HOST AND THERAPY: 
 The infection can occur due to injury, impairment of host defences, 
resuscitation or definitive care. Hypothermia can occur due to the exposure, 
infusion of large volume of unwarmed fluids or blood products, evaporative 
losses that occur during intracavitary surgery. Peripheral and cutaneous 
vasoconstriction occurs to preserve heat. But this leads to reduction in 
microcirculatory blood flow. Hypovolumia, inflammatory response, activation 
  
of coagulation pathway, decreased red blood cells pliability also leads to 
impairment. Hypothermia is immunosuppressive and affects cardiovascular 
performance thus increasing mortality following surgery or trauma. 
 Tissue hypoxia also leads to surgical site infections. This can occur due 
to injury to the face, airways, lungs, massive blood loss, microcirculation 
disruption, acute respiratory distress syndrome & cardiovascular instability. In 
studies conducted regarding hypoxia and surgical site infections they have 
concluded that administration of supplemental oxygen can lead to reduction in 
the incidence of surgical site infections. 
 Blood transfusion can be lifesaving following severe blood loss during 
surgery but it also acts as the source of infection. The blood transfusion can 
lead to altered leukocyte antigen presentation and a shift to the T helper cell 
phenotype. This leads to immunosuppression. Loss of membrane high energy 
phosphates following prolonged storage of blood products leads to impaired 
erythrocyte deformability, microcirculatory disruption and impaired oxygen 
offloading. Thus blood transfusion may not improve the oxygen consumption 
in severe sepsis but actually increase the organ dysfunction. It is always better 
to be conservative in the administration of blood products to the surgical 
patients in the intensive care units. 
CONTROL OF BLOOD SUGAR: 
 Hyperglycemia reflects the catabolism and insulin resistance associated 
with surgical stress. Hyperglycemia impairs host immune mechanism. Poor 
  
perioperative glycemic control leads to poor outcome following infections in 
surgical patients. Moderate hyperglycemia with blood sugar levels more than 
200 mg/dl has got fourfold increased risk of surgical site infections. Blood 
glucose level maintained at levels less than 110 mg/dl has got 40% reduced 
incidence of mortality among surgical patients. Nutritional control is essential 
to restore the anabolism. Calories in excess of basal requirements of 25-30 
kcal/day and nitrogen in excess of 1g nitrogen/kg/day will be required to 
restore the anabolism. Early enteral feeding within first 48 hours will be 
beneficial. 
INFECTION CONTROL:  
Infection control is one of the most important aspects in the control of 
surgical site infections. Central venous catheters must be inserted under strict 
aseptic precautions. Drains should be avoided and removed as soon as possible. 
Hand hygiene is the most important and effective way of reducing surgical site 
infection. Alcohol gel hand cleansers are effective against almost all pathogens 
except clostridium difficile spores which require cleansing with soap and 
water. Universal precautions such as cap, mask, gown, gloves and protective 
eye wear must be observed when there is a risk of splashing of body fluids.  
 Endogenous flora are the source of most common bacterial pathogens. 
Skin surfaces, airways, gut lumen, wounds, catheters and inanimate surfaces 
such as bed rails, computer terminals may become colonized. So if any break in 
natural epithelial barriers due to incisions, percutaneous catheters, airway or 
  
urinary catheters creates a portal for the entry of pathogens. The fecal-oral 
route is the most common way of transmitting the infection mainly because of 
health care personnel. Contact isolation remains the best method of infection 
control and it helps in the control of pathogens such as methcillin resistant 
staphylococcus aureus, vancomycin resistant enterococci. 
CATHETER CARE: 
Optimal catheter care includes 
1) Avoidance of catheter when unnecessary 
2) Appropriate skin preparation and barrier protection during insertion 
3) Proper catheter selection such as antimicrobial or antiseptic coated 
4) Proper dressing of indwelling catheters 
5) Removal of catheters as soon as no longer needed 
Almost all the catheters carry the risk of infection but nontunneled 
central    venous catheters and pulmonary artery catheters carry the highest risk. 
Endotracheal tubes, intercostal thoracotomy catheters, ventriculostomy 
catheters for intracranial pressure monitoring and urinary bladder catheters all 
carry the risk of infection. It is from these sources the infection can spread to 
surgical site. Each day of endotracheal intubation and mechanical ventilation 
increases the risk of surgical site infections by 1-3%.  
  
 Chlorhexidine gluconate in a concentration of 0.5-4% in combination 
with alcohol is bactericidal, viricidal and fungicidal. Chlorhexidine solution is 
superior to povidone iodine solution for vascular catheter insertions, bathing of 
critically ill patients.  If povidone iodine solution is used for surgical skin 
preparation then it should be allowed to dry for its microbicidal action. A single 
dose of first generation cephalosporin such as cefazolin will be required in case 
of emergency thoracostomy or ventriculostomy procedures. Sterile gloves and 
sterile field would suffice for urinary and arterial catheterization. Central 
venous catheters inserted under suboptimal conditions should be removed and 
reinserted at a different site within 24 hours.  
Dressing of the catheters should be maintained properly. Dressing 
materials should be maintained in adequate quantity for each patient separately 
and it should not be brought from patient to patient.  
 The choice of catheter also plays a role. Silver impregnated catheters 
play a role in reducing the catheter associated infections. Antibiotic or 
antiseptic impregnated catheters play a role in reducing the infections. 
Ventilator weaning by protocol such as daily sedation holidays, spontaneous 
breathing trials enables early extubation and reduces the risk of pneumonia. 
 
 
 
  
RISK FACTORS FOR THE DEVELOPMENT OF SURGICAL 
SITE INFECTIONS: 
  It can be divided into  
1) Patient factors 
2) Environemental factors 
3) Treatment factors 
PATIENT FACTORS: 
1) Ascites in case of abdominal surgery 
2) Chronic inflammation 
3) Corticosteroid therapy 
4) Obesity 
5) Diabetes 
6) Extremes of ages 
7) Hypocholesterolemia 
8) Hypoxemia 
9) Peripheral vascular disease 
10) Postoperative anemia 
11) Prior site irradiation 
  
12) Recent operation 
13) Remote infection 
14) Skin or nasal carriage of staphylococci 
15) Skin disease in the area of infection such as psoriasis 
16) Undernutrition 
 ENVIRONMENTAL FACTORS: 
1) Contaminated infections 
2) Inadequate disinfection or sterilization 
3) Inadequate skin antisepsis 
4) Inadequate ventilation 
 TREATMENT FACTORS: 
1) Drains 
2) Emergency procedure 
3) Hypothermia 
4) Inadequate antibiotic prophylaxis 
5) Oxygenation 
6) Prolonged preoperative hospitalization 
7) Prolonged operative time 
  
CLASSIFICATION OF SURGICAL WOUNDS: 
1) Clean wounds – these are the wounds in which no hollow viscus entered, 
primary wound closure done, no inflammation, no breaks in antiseptic 
technique & an elective procedure. It carries infection rate of 1-3%. 
2) Clean-contaminated wounds – these are in which hollow viscus entered but 
controlled, no inflammation, primary wound closure, minor break in 
antiseptic technique, mechanical drain used, bowel preparation 
preoperatively. It carries the infection rate of 5-8%. 
3) Contaminated wounds – uncontrolled spillage from viscus, inflammation 
apparent, open or traumatic wound, major break in aseptic technique. It 
carries infection rate of 20-25%. 
4) Dirty wounds – untreated, uncontrolled spillage from viscus, pus in 
operative wound, open suppurative wound, severe inflammation. It carries 
infection rate of 30-40%
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MICROBIOLOGY OF SURGICAL SITE INFECTIONS: 
   Gram positive organisms account for more than half of the infections. 
Staphylococcus aureus (most common), coagulase-negative staphylococcus, 
Enterococcus spp.. are the most common organisms isolated. Gram negative 
organisms such as Escherichia coli, Pseudomonas aeruginosa and Enterobacter 
spp., are isolated in one third of surgical site infections. In the National 
  
Nosocomial Infections Surveillance System the risk of patients is stratified 
according to three factors such as  
1)  wound classification(contaminated or dirty), 
2) longer duration of the operation, defined as one that exceeds the 75
th
 
percentile for a given procedure,  
3) medical characteristics of the patients as determined by American Society of 
Anesthesiology score of 3,4 or 5.  
Nowadays drug rersistant organisms such as Methicillin resistant 
Staphylcoccus or Vancomycin resistant Enterococcus are on rise
18
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PRESENTATION OF SURGICAL SITE INFECTIONS: 
 Symptoms of surgical site infections occur mostly within 30 days of the 
operative procedure. Superficial and deep surgical site infections are 
characterized by erythema, tenderness, edema and occasionally drainage. 
Wound will be soft or even fluctuant at the site of infection which is a 
departure from the usual firmness of the healing ridge present elsewhere in the 
wound
9
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According to the Joint Commission (TJC) the wound is said to be infected if 
1) There is drainage of grossly purulent material from the wound 
2) Wound spontaneously opens and drains purulent fluid 
  
3) Wound drains fluid that is culture positive or Gram stain positive for 
bacteria 
4) The surgeon notices the erythema or drainage and opens the wound 
after determining it to be infected
17
  
TREATMENT OF SURGICAL SITE INFECTIONS:    
Prevention of surgical site infections depends on identifying and 
removing the modifiable risk factors. Some of the risk factors such as age, 
morbid obesity and complexity of the procedure cannot be modified. 
Following things can be modified which includes 
1) Heavy smokers can be advised to stop smoking atleast 30 days prior to the 
procedure 
2) Glucose levels in diabetic patients must be corrected appropriately 
3) Severely malnourished patients should be given nutritional 
supplementation atleast 7 to 14 days prior to the procedure 
4) Obese patients must be encouraged to lose weight if the procedure is 
elective and if there is adequate time to achieve weight loss 
5) Patients on corticosteroid therapy should be weaned off the steroids or 
started at a lower dose 
  
6) Bowel preparation with lavage or cathartic and non absorbable oral 
antibiotic for the surgery of colon and small bowel can be done 
7) Hair can be removed by clipping and applying antiseptic solution to the 
site. 
8) Prophylactic antibiotics can be administered in certain procedures to 
prevent surgical site infections.  A first generation cephalosporin such as 
cefazolin would be required when placing a prosthesis such as in the case 
of hernioplasty. For patients undergoing upper gastrointestinal surgery or 
complex biliary tract operations, elective colonic resection, administration 
of a second generation cephalosporin such as cefoxitin or a beta lactamase 
inhibitor will be effective. For lower gastrointestinal surgeries ertapenem 
can be used. The timing of administration of the prophylactic antibiotic is 
crucial. To be most effective, the antibiotic has to be administered within 
30 minutes prior to making the incision so that the drug has reached 
therapeutic levels at the time of exposure to bacterial contamination. 
Drugs should not be administered for extended periods in the post 
operative period as it will lead to the development of drug resistant 
organisms and complications such as Clostridium difficile related colitis
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Precautions needed at the time of surgery for minimizing the surgical site 
infections. These includes 
1) Personal hygiene of the operating team such as hand scrubbing 
2) Thorough skin preparation of the patient 
3) Draping in a sterile fashion 
4) Careful handling of the tissues 
5) Meticulous dissection, hemostasis and debridement of devitalized 
tissue 
6) Compulsive control of intraluminal contents 
7) Preserving blood supply to the operated organs 
8) Elimination of foreign body from the wound 
9) Maintenance of strict asepsis by the operating personnel such as no 
hole in the gloves, avoiding the contaminated instruments, avoidance 
of environmental contamination such as debris falling from overhead 
10) Thorough drainage and irrigation of any purulent pockets with warm 
saline 
11) Ensuring the euthermic state of the patient 
  
 The use of intraperitoneal drains is always controversial. But the use of 
closed suction drains in very large or deep wounds and the wounds with very 
large flaps to prevent seroma or hematoma is a worthwhile practice. 
  Treatment of surgical site infections depends on the depth of the 
infection. For both superficial and deep infections, skin sutures or staples are 
removed over the area of infection and a cotton tipped applicator passed into 
the wound with efflux of purulent material or pus. If the fascia is intact then 
debridement of non vitalized tissue can be done. Thorough saline irrigation of 
the wound can be done and saline moistened gauze can be kept at the base of 
the wound to allow for the healing from base anteriorly and avoiding the 
premature skin closure. In case of widespread infection or fever, administration 
of intravenous antibiotics can be done. Choice of antibiotics can be decided 
according to the culture and sensitivity data. If there is breakdown of fascia 
then reoperation can be considered. 
 Most of the postoperative infections are allowed to heal by secondary 
intention. Delayed primary closure can also be attempted. In this case 
observation of the wound for 5 days can be done. If the wound is clean then 
primary closure of the skin can be done or the negative pressure wound therapy 
attempted. 
OBESITY AND SURGICAL WOUND:   
 Obesity is always considered as an important medical disease, which is 
significantly increasing in our country nowadays. Obesity is defined as body 
  
mass index more than 30kg/m
2 
based on the formula given as weight in kg 
divided by the height in metre square. Almost all healthcare professionals at all 
levels will be exposed to obese patients because of the higher risk for morbidity 
and mortality among the obese patients, and surgeons are not the exceptions 
who are regularly exposed to the most dreadful surgical complications of 
obesity. The common surgical procedures which are being done for obesity 
such as sleeve gastrectomy, gastric bypass procedures and also surgeries done 
for diseases seen in obese individuals are the common surgeries done in obese 
individuals. The degree of obesity can be measured by many methods. They are 
measured by the following indices: (a)Body mass index (BMI): this is the 
commonest  method to measure obesity in adults and in children. (b)Skin fold 
thickness(biceps, triceps, suprailiac and subscapular): it measures the 
subcutaneous fat which indicates the distribution of body fat.(c)Waist 
circumference : it is the common method to measure the risk of 
cardiometabolic affection . (d)Waist-to-hip ratio: it determines fat distribution 
and it is not used  frequently. (e)Waist-to-height ratio: waist-to-height ratio is a 
better screening tool compared to waist circumference and BMI to assess 
cardiometabolic risk factors in both sexes
2
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Risk of General Diseases Associated with Obesity 
Mortality 
  Obesity is identified as the fifth leading cause of death in the world. It is 
found incidentally that the death due to noncardiovascular diseases was 
inversely propotional to BMI. But nowadays obesity is found to be increasingly 
associated with the mortality in adults. The risk of morbidity and mortality is 
found to be proportionate with BMI. Malignancy and also cardiovascular 
diseases are found to be the most important cause of death in obese individuals. 
In addition, extreme degrees of fluctuation of weight found to be associated 
with higher risk of overall morbidity and mortality. 
Obese individuals tend to develop type 2 diabetes mellitus at all ages. 
Individuals with higher BMI and higher waist circumference are more prone to 
develop type 2 diabetes mellitus. This is because of the association between the 
various factors such as obesity, metabolic syndrome, impaired fasting glucose 
and impaired glucose tolerance. 
Hypertension 
 Increase in the prevalence of obesity is found to be associated with 
increase in the prevalence of systemic hypertension. Central obesity increases 
the risk of systemic hypertension among the population. Since both systemic 
hypertension and diabetes are frequently associated with obesity, it is proposed 
that hyperinsulinemia may be one of the causes for pathogenic connection 
  
between obesity and systemic hypertension. Factors such as age, sex, and race 
may alter the incidence of systemic hypertension in obese patients. 
 Dyslipidemia 
 Obesity also got a strong correlation with hyperlipidemia. This is 
characterized by high triglycerides level and low levels of high-density 
lipoprotein (HDL) cholesterol. The central obesity is associated with the high 
triglycerides, low HDL cholesterol, and high low-density lipoprotein (LDL) 
cholesterol. This can lead to atherogenic arterial diseases and also cardiac 
ailments. 
Heart Diseases 
 Obesity is considered to be an important risk factor for multiple heart 
diseases like coronary artery disease and rhythm abnormalities. Despite the 
concept that obesity is a risk factor of coronary artery disease, this relationship 
is confirmed by higher BMI and higher waist circumference, but the parameter 
waist-to-hip ratio can replace the BMI and waist circumference and it is found 
to be a better predictor of coronary artery disease. It is found to be more 
common in females as compared to males. Surprisingly, obesity is found to be 
commonly associated with more favorable short-term outcomes after acute 
coronary syndrome. Obesity has a strange correlation with heart failure and that 
is called as obesity paradox. It can result in systolic and diastolic dysfunction. 
On the other hand, obese patients with heart failure will be having better 
outcomes in comparison to patients with normal BMI. Obesity (regarding high 
  
BMI and waist circumference) has also got higher risk for the rhythm 
abnormalities like atrial fibrillation. Obstructive sleep apnea is also seen to be 
associated with obesity. 
Central Nervous System Diseases 
 Obesity has got adverse effect on vascular events (e.g., stroke) and 
nonvascular diseases (e.g., Alzheimer’s disease). In 2009, based on some 
studies conducted obesity was considered to be not associated with carotid 
atherosclerosis, but now it is the most significant risk factor due to cholesterol 
deposition in carotid artery. Cholesterol and triglyceride deposition in the 
intimal lining leads to narrowing of carotid artery and thereby leading to stroke. 
Obesity is a prime risk factor for prevalence of ischemic stroke; however, 
central obesity is one of the risk factors for developing ischemic stroke in men 
(hemorrhagic stroke is not related to obesity). Also obesity may result in 
impairment of executive and cognitive function. 
Respiratory Diseases  
Obesity can lead to many respiratory illnesses like obstructive sleep 
apnea and bronchial asthma. Obesity is found to be important in the 
pathogenesis of obstructive sleep apnea, severity and affecting the quality of 
life. Obesity also increases the risk and severity of bronchial asthma. Obesity is 
also found to be an important risk factor for airway hyper responsiveness but it 
is not a risk factor for airway inflammation. 
  
Gastrointestinal Diseases 
 Obesity can lead to esophageal motility disorders and Barrett esophagus, 
Gastroesophageal reflux disease and esophageal adenocarcinoma. Severity of 
the reflux symptoms and Barrett esophagus are highly related to BMI, waist 
circumference and waist-to-hip ratio. The risk of nonalcoholic fatty liver 
disease is also found to be increased in those with high BMI and with high 
waist to hip ratio. 
Kidney Diseases 
 Obesity can be related to a number of kidney diseases such as focal 
segmental glomerulosclerosis and chronic kidney disease. It is found that 
obesity is highly prevalent among the renal transplant recipients. As with 
obesity-survival paradox, it has an improved survival rate in dialysis patients. 
Osteoarthritis 
 Obesity is considered as a primary risk factor for the development and 
severity of hip (recently involved) and knee osteoarthritis. This is attributed to 
the biomechanical effects, pressure effects and metabolic effects of obesity on 
joints, which makes the joint more vulnerable to damage. 
Gynecological and Obstetric Complications 
 Overweight and obesity increase the overall risk of antenatal 
complications, delivery and neonatal complications. Pregnancy related 
  
complications are miscarriage, anovulation, gestational diabetes, preeclampsia, 
and gestational hypertension. Intra partum complications include prolonged 
first stage of labour and thus increase in the risk for cesarean section. Neonatal 
complications that can occur include birth injuries, congenital anomalies, 
abnormal intrauterine growth, macrosomia, perinatal asphyxia leading to fetal 
distress, neonatal respiratory distress, and childhood obesity. Obesity is highly 
associated with polycystic ovarian disease, metabolic syndrome and increases 
risk of developing some of the features like hyperandrogenism, hirsutism and 
infertility. 
Malignancies 
        Obesity is associated with higher rate of cancer incidence, recurrence, 
progression of malignancy and death. It can be held responsible for the 
following cancer types involving gastrointestinal system, hepatobiliary system, 
breast (premenopausal and postmenopausal), gynaecological, pulmonary, skin 
(malignant melanoma), hematological malignancies. 
The increased risk of cancer mortality in obese individuals is associated with 
BMI above 30kg/m
2
. 
Psychological Disorders 
 Obesity is also attributed to a number of mental illness in adults and 
children. These include psychosomatic disorders, eating disorders, obsessive-
compulsive disorder and others. 
  
Surgical Diseases Associated with Obesity 
Peptic Ulcer 
 Peptic ulcer is an important complication seen in obese individuals. And 
men are more prone to develop peptic ulcer. It was thought that Helicobacter 
pylori infection does not increase in overweight patients and incidence of 
peptic ulcer was inversely related to BMI. 
Pancreatic Diseases 
 Obesity is considered as a risk factor for pancreatic disorders such as 
pancreatitis and pancreatic malignancies. Severe acute pancreatitis is more 
frequent in obese individuals. Furthermore, obese patients are more prone for 
development of systemic and local complications of acute pancreatitis. Obesity 
is a poor prognostic factor in pancreatitis and overweight before the disease 
onset appears to be a risk factor for chronic pancreatitis. Obese individuals are 
found to have increased risk of pancreatic cancer at younger age. Obesity is 
associated with poor prognosis as well as increased mortality in pancreatic 
malignancy. However, there are controversies regarding the effects of obesity 
on long-term postoperative results in the patient with pancreatic cancer. 
Gall Bladder Diseases 
 In the gall bladder diseases, obesity and overweight have been known as 
prime risk factors for cholelithiasis. Obesity, insulin resistance and metabolic 
syndrome are attributed to many gallbladder diseases like gallbladder stones, 
  
cholecystitis, porcelain gallbladder, gallbladder malignancies, and gallbladder 
polyps. 
Appendicitis 
 Obesity has got no negative impact in the diagnosis of appendicitis 
except in children. Obese adults and children have higher risk for 
complications of appendicitis like appendicular perforation, appendicular mass, 
appendicular abscess and gangrenous appendicitis. 
Diverticulitis 
BMI, waist circumference and waist-to-hip ratio increase the risk 
fourfold for developing diverticulitis, diverticular bleeding, perforation, and 
recurrence. Studies conducted on few obese patients identified the presence of 
diverticulosis without diverticulitis. 
Hernia 
 There is a strong association between obesity and the presence of hiatus 
hernia thereby leading to GERD. In addition, incisional hernia is highly 
prevalent among obese individuals because of the thin abdominal musculature. 
Abdominal Trauma 
 Obese patients are more susceptible to road traffic accidents than 
general population due to the associated sleep apnea. They usually suffer from 
chest injuries, pelvic and extremity fractures. Unfortunately, these individuals 
  
carry a high risk for morbidity and mortality because of difficulty in proper 
assessment and treatment. 
Perioperative Complications Related to Obesity 
Preoperative Complications 
 Obesity is a risk factor for perioperative mortality and morbidity. 
Morbid obesity is a prime risk factor for mortality. Surgeries done for obesity 
related complications such as obstructive sleep apnea and also patients 
undergoing bariatric surgery are at increased risk for developing perioperative 
morbidity. Postoperative complications of obese patients are mainly due to 
their respiratory system. Respiratory complications can manifest as reduced 
tidal volume with increased atelectasis, lung and chest wall compliance and 
also moderate to severe hypoxaemia. These physiological alterations are more 
pronounced in obese individuals with hypercapnic syndrome or obstructive 
sleep apnea syndrome. 
Intraoperative Complications 
 The degree of obesity influences the incidence of intraoperative surgical 
complications. Intraoperative special considerations for obese individuals 
include requirements for special equipment, patient positioning, intravenous 
line placement, central monitoring lines, and anesthesia specific to the 
physiologic changes in obese patients. Also, airway management is a challenge 
for anaesthetist. Intravenous fluid administration, physiologic responses to 
  
pneumoperitoneum during laparoscopic procedure, risk of thrombotic 
complications and the peripheral nerve injuries in extremely obese patients are 
among the factors that present as a special intraoperative challenge that affect 
postoperative recovery of the bariatric patient. In regional anesthesia, obesity is 
found to have higher block failure and complication rates compared to general 
population. Obese and overweight patients undergoing resection for colorectal 
carcinoma when compared with normal-weight patients have similar 
intraoperative blood loss and postoperative complications but longer operative 
times. 
Postoperative Complications 
 Obese patients have a significantly higher risk of postoperative 
myocardial infarction, wound infection, nerve injury, urinary infection and 
DVT than do nonobese patients, and they may differ from other patients in 
supplemental oxygen requirements, medication dosing, and outcomes in 
intensive care units. Obese population has a higher than normal incidence of 
perioperative pulmonary embolism. Skin/wound problems which are common, 
yet more difficult to manage for these patients include pressure ulcers, 
tracheostomy care (potentially resulting from ventilatory insufficiency), 
candidiasis, tape-related skin tears, incontinence, and lymphedema. 
Laparoscopic versus Open Abdominal Surgeries 
 Evidence supports that laparoscopic approach results in better outcomes 
than open surgery with few exceptions. Laparoscopic surgery may be a safer 
  
treatment than open surgery for patients requiring bariatric surgery. 
Laparoscopic procedures are associated with shorter operative times, less blood 
loss, less postoperative pain and analgesic consumption, earlier postoperative 
recovery, shorter hospital stays, lesser degree of abdominal wall trauma, 
reduction in the rate of incisional hernia and pulmonary embolism and better 
respiratory function and cosmetic results. However, some laparoscopic 
procedures as laparoscopic-converted colon resection are associated with 
significantly greater morbidity, particularly wound complications and greater 
length of hospital stay compared to open surgery. In some surgeries, for 
example in appendectomy laparoscopic technique did not have superiority over 
the open one for obese patients. 
Bariatric Surgeries 
 Bariatric surgeries make tremendous improvement in obese patients’ 
health and life. They decrease overall obesity complications and improve the 
quality of life. They are indicated in patients with BMI > 40kg/m
2
 or 
>35kg/m
2
 with complications associated with obesity such as hypertension, 
type 2 diabetes mellitus and obstructive sleep apnea, as well as for those not 
improving with medical therapy. In very high-risk patients, staged approaches 
may be required in which one operation (either gastrectomy or intestinal 
bypass) is followed by the other operation in two separate surgical procedures. 
 
 
  
Types 
 Different types of bariatric surgeries were invented and developed since 
early 50s, through either open or laparoscopic techniques. They can be broadly 
categorized into restrictive operations, malabsorptive operations and 
combination operations. Restrictive operations include the adjustable gastric 
band and the sleeve gastrectomy. Malabsorptive operations include 
biliopancreatic diversion. A combination of restriction and malabsorption is 
represented by the Roux-en-Y gastric bypass and biliopancreatic diversion-
duodenal switch. 
Complications of Bariatric Surgeries in General 
(a)Mortality: operative (30-day) mortality for bariatric surgery ranges from 
0.1% to 2%. Mortality rates depend on several factors: complexity of the 
operation, patient comorbidities, patient body habitus, and experience of the 
surgeon and the center. Restrictive operations have lower mortality risk than 
malabsorptive operations. 
(b)Early complications: the severely obese patients are at risk of developing 
several general anesthetic complications such as thromboembolism, pulmonary 
or respiratory insufficiency, hemorrhage, peritonitis, and wound infection.  
(c) Late complications that includes the following: 
(i)  small bowel obstruction, 
  
(ii)  marginal ulceration that can occur at the site of anastamosis may 
present a frequent source of abdominal pain and anemia, 
(iii)  incisional hernias that can occur after open bariatric surgery and 
require subsequent surgical intervention, 
(iv) device-related complications with the gastric band which include 
malfunctioning of the band, tubing, or reservoir component, 
(v)  hypoglycemia 
(vi)  bowel disturbances such as steatorrhea, diarrhea, and bacterial 
overgrowth that are more common with malabsorptive procedures, 
(vii) nutritional deficiencies of micronutrients, 
(viii)neurological complications that can occur include peripheral 
neuropathy, burning feet syndrome, meralgia paresthesia, myotonic 
syndrome, posterolateral myelopathy, myotonic syndrome, optic 
neuropathy, Wernicke-Korsakoff encephalopathy and lumbosacral 
plexopathy
2
. 
DRAINS IN SURGERY: 
  A drain is a created channel which allows any collected fluid (blood, pus 
and any other fluids) to come out after closure of the main wound. 
Subcutaneous drain is used to remove the collected fluid, obliterates the dead 
space and thereby prevents fluid collection in subcutaneous space. A tube drain 
can also be used to give wash through it
3
. 
  
CLASSIFICATION I 
1. Closed drain and open drain 
2. Active and passive drain - active drains are maintained under 
suction, passive drains work by the difference in pressure between 
the cavity and exterior 
3. Red rubber drain and sialastic drain
4
. 
CLASSIFICATION II 
1) Corrugated rubber drain - this drain is based on the principle of capillary 
action and gravity. But the drain which comes out causes soakage of the 
dressing and also if poorly maintained, it can lead to the introduction of 
infection from outside inwards. 
2) Glove drain  
3) Sump drain - a parallel air vent is present in this system, so that it 
prevents the neighbouring tissues being sucked. Sump drain never gets 
blocked because of the air vent. 
4) Tube drains includes Malecot catheter drain, Penrose soft latex rubber 
tube drain, multiple perforated tubes. 
5) Closed suction tube drain. 
6) Wick drain - in this case a gauze drain kept to drain pus, discharge
1
. 
  
CLASSIFICATION OF DRAIN SYSTEM: 
1) Open (static) drains: this includes corrugated drains, penrose drains. 
Infection rate is higher. 
2) Closed siphon drains: here drain is connected to a sterile bag with or 
without one way valve. It reduces the infection. 
3) Closed suction drain: here negative pressure applied to create vacuum to 
drain the secretions. The negative pressure maintained in a suction drain 
is about 70 to 170 mm Hg. 
4) Sump suction drains: here negative suction with a parallel air vent is 
used to prevent the adjacent soft tissues being sucked into the lumen of 
the drain. 
5) Underwater seal drain to drain pleural space
5
. 
DRAIN MANAGEMENT 
 The indications for applying a surgical drain are  
1. To collapse the dead space in areas of excessive redundant tissue. 
2. To enable focused drainage of pus in abscess, thereby preventing 
premature closure of abscess cavity. 
3. To ensure the warning of surgical leak (faeces, urine). Hence it is known 
as sentinel drain. 
4. To control an established fistula leak
6
. 
  
 
 
 
 
 
 
ADVANTAGES OF TUBE DRAINS: 
1) Quantity of fluid like bile, pus can be measured. 
2) It can be kept for longer times. 
3) Skin excoriation will not occur. 
4) Patient will be more comfortable. 
5) Infection rate is less. 
6) Removal is easier. 
7) Dye can be injected and cavity or communication can be assessed using 
‘C-ARM’. 
8) Collection of irritant discharge. 
9) Collection of secretion having activated enzymes. 
  
Corrugated drain works by capillary action and gravity. It is technically 
feasible. The main disadvantage of corrugated drain is soakage of dressing 
which may cause discomfort to the patient. 
 
 
 
 
 
 
 
Sialastic drains are inert. Red rubber drain creates an intense 
inflammatory tissue reaction around the tube, thereby they have more chance to 
develop permanent tract. Sometimes drain acts as a controlled fistula when 
there is leak. Corrugated drain is an open drain, the end of the corrugated drain 
is covered with a sterile gauze. Infection rate is more with corrugated drain 
than compared with tube drain. 
 
 
 
  
DRAIN CARE 
.   1) Daily sterile dressing should be done around the drain site. 
    2) The drain should be emptied daily by measuring the quantity and nature 
of the drain. Drain can be removed according to the amount of fluid drained.  
The use of antibiotic when drain is in place is often unnecessary as the 
drain enables direct source control. Prophylactic antibiotics can be given 24 to 
48 hrs after drain placement. 
COMPLICATIONS OF DRAIN                                  
Drains can get blocked or occluded by flakes or clot. If they are 
occluded it results in retaining of fluid that can contribute to infections. The 
patency of the drain should be checked frequently. Once the drain is blocked 
the drain should be removed immediately. Rate of infection is increased if the 
drain is dislodged. When the drain is dislodged it may not drain adequately and 
it gives a false impact. Sometimes drain may delay the healing process inside
21
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OBESITY AND SUBCUTANEOUS FAT THICKNESS: 
  Subcutaneous fat is the adipocytes found beneath the skin. Subcutaneous 
fat acts as a shock absorber and acts as a cushion to the underlying vital 
structures. The adipocytes found deep inside the body is known as visceral fat. 
The thickness of subcutaneous fat is an important indicator of obesity. 
  
Thickness of subcutaneous fat will be increased in obesity. If the thickness is 
more with fibrous septa in between, it is known as cellulite. 
 
  
 
 
  
Subcutaneous fat thickness is measured using harpenden’s skin caliper, 
ultra sound and computed tomography. Ultrasound is operator dependent. 
Optical lipometer device is a newer device to determine the subcutaneous fat 
thickness. Common laboratory methods include densitometry from under water 
weighing or air displacement phlethysmography, hydrometry from isotope 
dissolution and dual energy Xray absorptiometry. Other methods such as bio 
electrical impedence, anthropometric measurements involve easy 
measurements with portable instruments
23
. 
 Laboratory methods cannot differentiate between subcutaneous fat from 
visceral fat. Ultrasound can measure the thickness of subcutaneous fat at any 
specific sites. Midline abdominal subcutaneous fat thickness was measured 
transversely at one centimeter caudal to umbilicus. The normal midline 
abdominal subcutaneous fat thickness measured at the level of umbilicus 
ranges from 2 to 3 cm
2
. 
  
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
STUDY DESIGN, METHODOLOGY AND TECHNIQUES 
TITLE-ROLE OF PROPHYLATIC SUBCUTANEOUS DRAIN IN 
OBESE PATIENTS UNDERGOING ELECTIVE ABDOMINAL 
SURGERY IN CMCH.-A COHORT STUDY 
STUDY DESIGN-Prospective cohort study 
METHODOLOGY 
SAMPLE SIZE-150 
INCLUSION CRITERIA 
1.  Patients with BMI of more than 32. 
2.  Patients with subcutaneous fat thickness of more than 3 cms 
3. Patients undergoing elective abdominal surgeries like ventral 
hernia repair,gastric surgeries and colo rectal surgeries etc.  
4. Patients of either sex with age of between 20-60years. 
EXCLUSION CRITERIA 
1. Patients with sepsis and spillage. 
2. Patients undergoing laparoscopic surgery. 
3. Patients undergoing revision surgeries. 
  
4. Patients with associated comorbidities such as diabetes, advanced 
malignancy, steroid intake, radiotherapy, hepatic and renal 
insufficiency. 
 MATERIALS AND METHODS 
  It is a prospective open comparative study carried over a period of one 
year. Patients were randomized before surgery and divided into two groups by 
systemic random sampling. Total sample size 150 with 75 in each group.  
All patients will receive same preparations. 
1. Enema in morning of day of surgery. 
2. Patients should take shower1day before surgery and body hair removal 
3. Surgical field disinfected by use of povidone iodine. 
4. Injection cefotaxime 1g i.v just before skin incision. 
5. Skin incision made with scalpel. 
6. Subcutaneous fat dissected with electrocautery. 
7. Surgical instruments to be exchanged just before muscle Closure. 
8. Wound irrigated with saline just before skin closure. 
9. Subcutaneous layer closed with chromic catgut. 
  
10. Only closed tube drain is preferred since corrugated drain itself can 
predispose infections. 
11. Subcutaneous drain placed along the entire length of subcutaneous tissue. 
12. Exit of the drain should be separated from the main wound. 
13. Drain is removed when the output is less than 30 ml/day for 2days. 
14. Daily sterile dressing done in the post operative period. 
15. The contents in the drain is measured daily and drain is emptied daily. 
16. The outcome is measured with the following parameters such as seroma, 
hematoma, pain and surgical site infection. 
17. All the patients are discharged only after the subcutaneous drain is 
removed. 
18. Seroma is collection of clear fuid in the incision site. It is identified by 
discharge of clear immature fluid from the wound. 
 
19. Hematoma is abnormal collection of blood in the incision site. It manifest 
as localized swelling with bluish discoloration of the overlying skin with 
dark red fluid discharging through the wound. 
 
20. Surgical site infection is identified with drainage of frank pus from the 
wound with or without clinical features of infection.  Culture may be 
positive or negative. 
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Table 1 shows the mean age of the patients in the study
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Table 2 shows the gender distribution of the patients in the study.57.3% 
represents males and 42.7% represent females in the study
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RESULTS 
Table 1: Mean age of the study 
N Mean ±SD
150 39.50±9.1
 
Table 2: Gender distribution 
Frequency Percent (%)
86 57.3
64 42.7
150 100.0
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Table 3: Mean Body mass index (BMI) of the study
Mean 
Body mass index(BMI)
Table 3 shows the mean Bo
Table 4: Mean Subcutaneous Fat Thickness (Cm) of the study
Mean 
Subcutaneous Fat 
Thickness(Cm) 
Table 4 shows the mean subcutaneous fat thickness (cm) of the patients in the 
study  
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N Mean ±SD
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MEAN SUBCUTANEOUS FAT 
THICKNESS (CM) 
3.68
 
 
 
 
 
Subcutaneous drain
Present 
Absent 
Total 
 
Table 5 shows the subcutaneous drain among the patients in the study
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Table 5: Subcutaneous drain 
 Frequency Percent (%)
75 50.0
75 50.0
150 100.0
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Table 6: Subcutaneous drain with mean age
Mean Subcutaneous
drain
 
Age 
Present
Absent
Table 6 shows the subcutaneous drain with mean age among the patients in the 
study. Mean age of the patients with subcutaneous drain was 40.76±9.4 and 
Mean age of the patients without subcutaneous drain was 38.24±8.7 and it is 
not Statistically Significant (P>0.05) using independent ‘t’ test.
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Table 7: Subcutaneous drain in Gender
Subcutaneous 
drain 
Present 
Absent 
Table 7 shows the association of subcutaneous drain with respect to gender 
among the patients in the study. Among males subcutaneous drain was present 
in 60% and absent in 54.7%. Among females subcutaneous drain was present 
in 40% and absent in 45.3% and it is not Statistically Significant (P>0.05) 
using chi-square test. 
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PRESENT
ABSENT
 
P value 
 
.509 
Table 8: Subcutaneous drain with mean Body mass index (BMI)
Mean Subcutaneous 
drain
Body mass 
index (BMI) 
Present
Absent
*-Statistically Significant (P<0.05)
Table 8 shows the association of subcutaneous drain with respect to mean 
Body mass index (BMI) among the patients in the study. .
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Table 9: Subcutaneous drain with mean Subcutaneous Fat Thickness (Cm)
Mean Subcutaneous 
drain
Subcutaneous 
Fat 
Thickness(Cm) 
Present
Absent
*-Statistically Significant (P<0.05)
Table 9 shows the association of subcutaneous drain with respect to mean 
Subcutaneous Fat Thickness (Cm) among the patients in the study.
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Table 10: Wound Complications in patients with Subcutaneous drain
Subcutaneous 
drain 
Present 
Absent 
*-Statistically Significant (P<0.05)
Table 10 shows the association of 
Subcutaneous drain   
wound complications was present in 8% and absent in 92%. Among patients 
without subcutaneous drain wound complications was present in 33.3%, absent 
in 66.7% and it is Statistically Significant (P<0.05) using chi
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Table 11: Intervention in patients with subcutaneous drain
Subcutaneous 
drain 
Present 
Absent 
*-Statistically Significant (P<0.05)
Table 11 shows the association of intervention done among the patients with 
subcutaneous drain in the study. Among patients with subcutaneous drain 
intervention was done in 5.3% and was not done in 94.7%. Among patients 
without subcutaneous drain intervention was done in 33.3%, was not done in 
66.7% and it is Statistically Significant (P<0.05) using chi
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Table 12: Mean duration of hospital stay in 
Mean Subcutaneous 
drain
Duration of 
hospital stay 
Present
Absent
*-Statistically Significant (P<0.05)
Table 12 shows the association of mean duration of hospital stay am
patients with subcutaneous drain  in the study. Mean duration of hospital stay 
of the patients with subcutaneous drain was 5.25±2.3 days and mean duration 
of hospital stay of the patients without subcutaneous drain was 8.6±6.5 days 
and it is  Statistically Significant (P<0.05) using independent ‘t’ test.
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Table 13: Wound complications with intervention done among patients 
with subcutaneous drain ( n=75)
Wound 
complication 
 
Yes 
No 
*-Statistically Significant (P<0.05)
Table 13 shows the association of Wound complications with intervention 
done among patients with subcutaneous drain in the study.  Patients having 
subcutaneous drain with Wound complications, intervention w
66.7% and was not done in 33.3%. Among patients without Wound 
complications intervention was done in 0%, not done in 100% and it is 
Statistically Significant (P<0.05) using chi
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Table 14: Wound complications with intervention 
without subcutaneous drain (n=75)
Wound 
complication 
 
Yes 
No 
*-Statistically Significant (P<0.05)
Table 14 shows the association of Wound complications 
done among patients without subcutaneous drain in the study. Patients not 
having subcutaneous drain with Wound complications, intervention was not 
done in 0% and was done in 100%. Among patients without Wound 
complications, intervention w
Statistically Significant (P<0.05) using chi
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Table 15: Wound complication
Subcutaneous drain 
 
Present 
Absent 
*-Statistically Significant (P<0.05)
Table 15 shows the association of Wound complications 
patients with subcutaneous drain in the study.  Patients having subcutaneous 
drain with Wound complications
100%. Patients not having subcutaneous drain with Wound complications
seroma were present in 18.7% and absent in 81.3% and it is Statistically 
Significant (P<0.05) using chi
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Table 16: Wound complication
Subcutaneous drain 
N=150 
Present 
Absent 
*-Statistically Significant (P<0.05)
Table 16 shows the association of Wound complications 
patients with subcutaneous drain in the study.  Patients having subcutaneous 
drain with Wound complications
100%. Patients not having subcutaneous drain with
hematoma were present in 6.7% and absent in 93.3% and it is Statistically 
Significant (P<0.05) using chi
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Table 17: Wound complication
patients with subcutaneous drain
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*-Statistically Significant (P<0.05)
Table 17 shows the association of Wound complications 
infection (SSI) among patients with subcutaneous drain in the study.  Patients 
having subcutaneous drain with Wound complications
(SSI) were present in 2.7% and absent in 97.3%. Patients not having 
subcutaneous drain with Wound compli
were present in 14.7% and absent in 85.3% and it is Statistically Significant 
(P<0.05) using chi-square test
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Table 18: Wound complication
Subcutaneous drain
N=150 
Present 
Absent 
Table 18 shows the association of Wound complications 
patients with subcutaneous drain in the study.  Patients having subcutaneous 
drain with Wound complications
94.7%. Patients not having subcutaneous drain with Wound complications
Pain were present in 14.7% and absent in 85.3% and it is not Statistically 
Significant (P>0.05) using chi
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Table 19: Type of abdominal surgery among patients 
Type of abdominal surgery Frequency 
Percent 
(%) 
ABDOMINAL HYSTERCECTOMY 7 4.6 
CHOLECYSTECTOMY 28 18.7 
CYSTOGASTROSTOMY 6 4.0 
CYSTOJEJUNOSTOMY 4 2.7 
EPIGASTRIC HERNIA REPAIR 15 10.0 
GASTRECTOMY 11 7.3 
INCISIONAL HERNIA REPAIR 17 11.3 
LEFT HEMICOLECTOMY 4 2.7 
NISSEN'S FUNDOPLICATION 8 5.3 
PANCREATICOJEJUNOSTOMY 7 4.7 
PARAUMBILICAL HERNIA 
REPAIR 
27 18.0 
RIGHT HEMICOLECTOMY 6 4.0 
VAGOTOMY WITH GJ 6 4.0 
WHIPPLE'S PROCEDURE 4 2.7 
Total 150 100.0 
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DISCUSSION 
 Any surgery in obese individuals will have complications whether done 
electively or emergency. Local wound complications can occur in obese 
individuals. These include seroma, hematoma, wound dehiscence and surgical 
site infections. Local wound complications increase the morbidity of the 
patient. These complications will prolong the hospital stay of the patient and 
cause economic burden to the patient. Local wound complications occur more 
frequently in obese individuals. This occurs due to the increased subcutaneous 
fat thickness in these patients. So after skin incision with scalpel, during the 
dissection of subcutaneous plane, the use of diathermy to arrest bleeding points 
in subcutaneous plane will all lead to the subcutaneous fat lysis and seroma 
formation. Any bleeding point in subcutaneous plane if not arrested properly 
could lead to hematoma formation in wound. These collections in the wound 
act as a nidus for infection. Surgical site infections are dangerous because of 
the emergence of multidrug resistant organisms. These complications will lead 
to wound failure or dehiscence. Wound dehiscence cannot be sutured 
secondarily because of persisting wound infection and also discharging seroma 
or hematoma. They have to be treated daily with cleaning and dressing, 
intravenous antibiotics according to culture and sensitivity reports. All the 
collections underneath the wound has to be let out. If seroma or hematoma not 
drained adequately, it could lead to secondary infection with pus formation and 
foul smelling purulent discharge. Because of these complications, hospital stay 
of patients will be prolonged and also mobilization of patients also delayed. 
  
This could lead to respiratory complications. So obese patients should be 
encouraged to lose weight before undergoing elective abdominal surgeries like 
ventral hernias, cholecystectomy for gall stone disease. Patients with 
abdominal malignancies needs to be operated immediately. There will be no 
time for these patients to undergo weight loss program. Obese patients with 
huge incisional hernia will have increased risk of abdominal compartment 
syndrome. This can be addressed with creating sequential pneumoperitoneum 
to increase the abdominal capacity. And respiratory complications in these 
patients can be addressed by doing respiratory exercises such as incentive 
spirometry. Many methods have been developed to reduce the local wound 
complications. These methods include the placement of a subcutaneous drain to 
let out the collections underneath the wound, administration of intravenous 
antibiotic prior to making the skin incision to reduce the surgical site 
infections. Subcutaneous drains help to let out the seroma, hematoma and any 
purulent discharge. This reduces the chance of wound dehiscence. This helps in 
the faster recovery of the patient and early mobilization of the patient. 
 In our study the role of subcutaneous drains in the obese individuals 
undergoing elective abdominal surgeries have been studied. Obese individuals 
with body mass index more than 32 kg/m2. BMI is measured with quetelet 
index. Subcutaneous fat thickness of more than 3 cm undergoing elective 
laparotomy were included. In our study we measured the subcutaneous fat 
thickness with ultrasound and subcutaneous fat thickness is measured in the 
midline of the abdomen 1cm caudal to umbilicus. It is a prospective cohort 
  
study involving hundred and fifty obese patients with forementioned criteria. 
Subcutaneous tube drains kept in seventy five patients. The drain is removed 
when the output is less than 30 ml/day for 2 days. Another seventy five patients 
without subcutaneous drains were compared for the occurrence of local wound 
complications such as seroma, hematoma, wound dehiscence and surgical site 
infections. The parameters such as length of hospital stay, number of patients 
requiring intervention studied. The results are compared among the two groups. 
All the patients are discharged only after drain removal. 
 The study group consists of 150 patients. Total male patients in the 
study group is 86 and the female patients is 64. The mean age group of the 
patients included in the study is around 40 years. Mean body mass index of the 
study group is 34.40 kg/m2. Mean subcutaneous fat thickness of the obese 
patients included in the study is 3.68cm. Subcutaneous drains used in 75 
patients and not used in 75 patients. The patients are selected by systemic 
random sampling. Mean body mass index of the patients with subcutaneous 
drain is 35.33 kg/m2. Mean body mass index of the patients without 
subcutaneous drain is 33.47 kg/m2. Mean subcutaneous fat thickness of the 
patient with subcutaneous drain is 4.04cm. Mean subcutaneous fat thickness of 
the patient without subcutaneous drain is 3.31cm.  
Wound complications observed in 6 patients with subcutaneous drain 
which forms 8% of the total patients with subcutaneous drain. Wound 
complications observed in 25 patients without subcutaneous drain which forms 
33.3% of the total patients without subcutaneous drain. Comparing these two 
  
data found to be statistically significant with P value < 0.05. Thus the incidence 
of wound complication is low in those with subcutaneous drain than those 
without drain. 
Wound complications such as seroma, hematoma, pain and surgical site 
infections studied. In our study Seroma occurred in 14 patients in whom the 
subcutaneous drain was not kept which represents 18.7% of those without 
subcutaneous drain. Intervention was done in all 14 patients. Seroma evacuated 
by removing one or two sutures and applying pressure dressing over it. Seroma 
resolved in all the 14 patients. The maximum duration of stay in hospital for 
the patients with seroma is 21 days. Thus the development of seroma is more 
with the patients without subcutaneous drain when compared to those with 
subcutaneous drain. 
In our study Hematoma occurred in 5 patients in whom the 
subcutaneous drain was not kept, which represents 6.7% of those without 
subcutaneous drain. Patients presented with localized swelling with bluish 
discoloration of overlying skin. Hematoma is evacuated under local anaesthesia 
with sterile aseptic precautions and daily dressing done. Thus the occurrence of 
hematoma is more in patients without subcutaneous drain than compared to 
those with  subcutaneous drain.  The maximum duration of hospital stay is 25 
days. 
In our study 15 patients developed pain. Pain at the wound site occurred 
in 4 patients with subcutaneous drain representing 5.3% of those with drain. 
  
And pain occurred in 11 patients without subcutaneous drain representing 
14.7% of those without drain. All the 13 patients are treated with analgesics 
such as injection tramadol , paracetamol infusion. The pain in 2 patients 
resolved with oral analgesics . It is found that subcutaneous drain has no impact 
in development of pain. The maximum duration of hospital stay is 14 days for 
those patients with pain alone. 
     In our study it is considered that patients who presents with pus 
discharge(culture positive or culture negative),who presents with clinical 
features of infection comes under surgical site infection. In our study 13 
patients developed SSI. It is found to be superficial SSI in all 13.Surgical site 
infections occurred in 2 patients with subcutaneous drain which represents 
2.7% of those with drain. And surgical site infections occurred in 11 patients 
without subcutaneous drain which represents 14.7% of those without drain. 
Intervention is done in all the 13 patients. Antibiotics are started according to 
culture & sensitivity and wound cleaning and dressing done three times a day. 
Among the 13 patients,  2 patients developed wound gaping without drain for 
which wound debridement and secondary suturing done. Thus the incidence of 
SSI is more in those without subcutaneous drain than those with subcutaneous 
drain. The maximum duration of hospital stay is 21days. 
Thus seroma and hematoma occurred only in patients without 
subcutaneous drain. Pain at the wound site is seen in patients with 
subcutaneous site also. Surgical site infections occurred in less number of 
patients with subcutaneous drain. 
  
Intervention needed for 25 patients without subcutaneous drains which 
forms 33.3% of the group without drain. Intervention needed only for 4 patients 
with subcutaneous drain which forms 5.3% of the group with drain. On 
comparing these two data, P value is found to be less than 0.05 which is 
statistically significant. Thus intervention is done in more number of patients 
without subcutaneous drain than those with subcutaneous drain. 
 Also the group of patients with subcutaneous drain had mean stay in the 
hospital of 5 days. Mean stay of the patients with subcutaneous drain is low 
when compared with the mean stay of 8.6 days for the group of patients 
without subcutaneous drain. 
Thus subcutaneous drain when kept in obese individuals with more 
subcutaneous fat thickness who undergo elective abdominal surgeries had 
lesser incidence of local wound complications and lesser hospital stay when 
compared to those patients without subcutaneous drain. 
 
 
 
 
 
 
  
CONCLUSION 
 Obese patients undergoing elective laparotomy suffer from local wound 
complications such as seroma, hematoma, pain at the wound site, wound 
dehiscence and surgical site infections. These complications occur because of 
increased subcutaneous fat thickness, poorly controlled bleeding points in 
subcutaneous plane, poorly maintained aseptic precautions, improper surgical 
techniques. These will lead to increased morbidity for the obese patients and 
prolonged hospital stay. These complications can be reduced with the use of 
subcutaneous  drain to let out the collections in the wound. In our study we 
found that obese patients undergoing elective laparotomy with subcutaneous 
drains had no seroma, no hematoma and lesser incidence of surgical site 
infections. Only few patients needed intervention in the form of secondary 
suturing of the wound when compared with patients without subcutaneous 
drain. Also the hospital stay of the patients with subcutaneous drain is lower 
when compared with those without subcutaneous drain. Thus placement of a 
subcutaneous drain in obese individuals with increased subcutaneous fat 
thickness helps in reducing the local wound complications and reducing the 
hospital stay of the patients and also aids in faster recovery.  
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           CONSENT FORM 
 I,     , do hereby volunteer and consent to participate 
in this  study being conducted by Dr.A.Priyadharshini on “ROLE OF 
PROPHYLACTIC SUBCUTANEOUS DRAIN IN OBESE PATIENTS 
UNDERGOING ELECTIVE ABDOMINAL SURGERY IN CMCH – A COHORT 
STUDY”. I have read and understood the consent form or it has been read and 
explained to me in my own language. The study has been fully explained to me and I 
may ask questions at any time. 
 
 
Signature / Left Thumb Impression of the Volunteer             Date:                 Place: 
 
 
Signature and Name of witness                                             Date:                  Place: 
 
 
Signature of the investigator: 
 
 
Name of the investigator:               
  
 
xg;g[jy; gotk;; [ ; ;; [ ; ;; [ ; ;  
 
vdf;F cly;gUkd; ,Ug;gjhy; mWit rpfpr;irapd; nghJ 
njhYf;F fPH; tofhy; FHha; (Drain) itf;f ntz;Lk; vd;gij 
kUj;Jth; \yk; mwpe;J bfhz;nld;. mt;thW tofhy; FHha; 
itg;gjd; \yk; fpUkp bjhw;W Vw;gLtij jLf;fyhk; vd;gija[k; 
Twpdhh;. cly; gUkd; ,Ug;gjhy;  ijay; nghl;l ,lj;jpy; ePh; 
kw;Wk; ,uj;jk; nfhh;f;fyhk; vdt[k;/ ijay; tpl;L nghfyhk; 
vd;gija[k; Twpdhh;. mjdhy; njhYf;F moapy; tofhy; FHha; 
itj;J nkny Twpa[s;s gpur;ridfis jLf;fyhk;/ vd;gija[k; 
Twpdhh;. ,it midj;ija[k; gw;wpa[k;/ Muha;r;rp bra;tij 
gw;wpa[k; kUj;Jth; tpsf;fpdhh;. ,it midj;Jk; mwpe;J KG 
kdJld; ,jw;F rk;kjk; mspf;fpnwd;. 
 
,g;gof;F 
 
 
 
 
 
  
ANNEXURE II 
 PROFORMA  
 
NAME :    AGE :  SEX : 
I.P. NO :      
 OCCUPATION:  
ADDRESS :        
HEIGHT : 
WEIGHT :  
BMI :  
SUBCUTANEOUS FAT THICKNESS 
DIAGNOSIS : 
PROCEDURE : 
DOA :       DOS :   
DOD :                     
SUBCUTANEOUS DRAIN  YES/NO     
COMORBID CONDITIONS  YES/NO 
COMPLICATION    YES/NO 
SEROMA     YES/NO 
HEMATOMA    YES/NO 
SSI                                                       YES/NO 
PAIN                                                    YES/NO 
INTERVENTION DONE                    YES/NO   
 
  
S.NO. NAME AGE SEX
BODY MASS 
INDEX(KG/
M2)
SUBCUTANEOUS 
FAT 
THICKNESS(CM)
TYPE OF ABDOMINAL 
SURGERY
SUBCUTANEOUS 
DRAIN
WOUND 
COMPLICATIONS
INTERVENTION 
DONE 
DURATION 
OF HOSPITAL 
STAY
SEROM
A
HEMAT
OMA SSI PAIN
1 RATHINASAMY 44Y M 32.5 3.2 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
2 PREMA 38Y F 34 4.1 INCISIONAL HERNIA REPAIR P NO NO 4 DAYS NO NO NO NO
3 MANIVASAGAM 42Y M 33 4 GASTRECTOMY A NO NO 7 DAYS NO NO NO NO
4 PONNAIYAN 50Y M 33.2 3.8 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
5 MUTHULAKSHMI 48Y F 36.4 4.2 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
6 KAMALA 45Y F 37.8 4.7 PARAUMBILICAL HERNIA REPAIR A YES YES 15 DAYS YES NO NO NO
7 RANGARAJAN 36Y M 34.2 3.4 PANCREATICOJEJUNOSTOMY A NO NO 7 DAYS NO NO NO NO
8 KANNAPAN 55Y M 36 3.7 RIGHT HEMICOLECTOMY P NO NO 8 DAYS NO NO NO NO
9 THANGARAJU 51Y M 32.4 3.1 EPIGASTRIC HERNIA REPAIR A YES YES 14 DAYS YES NO YES NO
10 MALADEVI 40Y F 38.4 5.2 ABDOMINAL HYSTERCECTOMY P YES YES 10 DAYS NO NO YES NO
11 SARASWATHY 47Y F 34.6 4.1 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
12 SELVI 40Y F 32.5 3.1 PARAUMBILICAL HERNIA REPAIR A NO NO 5 DAYS NO NO NO NO
13 KUMARASAMY 49Y M 32.6 3.4 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
14 LALITHA 39Y F 35.2 3.9 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
15 MARUTHACHALAM 51Y M 32.3 3 NISSEN'S FUNDOPLICATION A NO NO 4 DAYS NO NO NO NO
16 NAGALAKSHMI 48Y F 32.4 3.1 ABDOMINAL HYSTERCECTOMY A YES YES 18 DAYS YES NO NO NO
17 VIJAYA 47Y F 34.8 4.2 VAGOTOMY WITH GJ P NO NO 4 DAYS NO NO NO NO
18 MUTHHUKUMARAN 43Y M 32.5 3.4 CYSTOGASTROSTOMY P NO NO 4 DAYS NO NO NO NO
19 NAGARATHINAM 37Y F 32.6 3.4 INCISIONAL HERNIA REPAIR A YES YES 16 DAYS YES NO NO NO
20 BABY 42Y F 32.5 3.2 PARAUMBILICAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
21 KANNAN 54Y M 34.5 3.7 LEFT HEMICOLECTOMY P NO NO 7 DAYS NO NO NO NO
22 KARTHIKEYAN 49Y M 36.8 4.2 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
23 MEENAKSHISUNDARAM 51Y M 34.7 3.5 PANCREATICOJEJUNOSTOMY A NO NO 7 DAYS NO NO NO NO
24 KALPANA 44Y F 32.8 3.1 PARAUMBILICAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
25 RAGHURAMAN 35Y M 34.5 3.3 WHIPPLE'S PROCEDURE P NO NO 8 DAYS NO NO NO NO
26 RAVICHANDRAN 27Y M 37.4 4.4 GASTRECTOMY P YES NO 12 DAYS NO NO NO YES
27 DEVIPRIYA 34Y F 33.4 3.2 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
28 MURUGAMMAL 48Y F 32.8 3.1 PARAUMBILICAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
29 LATHA 26Y F 34.7 3.5 PARAUMBILICAL HERNIA REPAIR A YES YES 14 DAYS YES NO NO NO
30 MURUGESAN 41Y M 32.6 3.2 INCISIONAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
31 KADHAR ALI 46Y M 34.2 3.3 RIGHT HEMICOLECTOMY P NO NO 8 DAYS NO NO NO NO
32 ANTONY WALTER 41Y M 32.4 3.1 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
33 REENA 28Y F 32.5 3.2 INCISIONAL HERNIA REPAIR A YES YES 15 DAYS YES NO NO NO
34 THENNAPAN 55Y M 36.7 4.6 CYSTOJEJUNOSTOMY P NO NO 5 DAYS NO NO NO NO
35 LAVANYA 29Y F 32.5 3.6 WHIPPLE'S PROCEDURE P NO NO 8 DAYS NO NO NO NO
36 RITHANYA 24Y F 39.5 5.8 PARAUMBILICAL HERNIA REPAIR P YES YES 8 DAYS NO NO YES NO
37 VENAKATACHALAM 44Y M 32.5 3.2 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
38 MOHAMMED FAISAL 37Y M 35.2 4.5 NISSEN'S FUNDOPLICATION A YES YES 17 DAYS YES NO YES NO
39 GEETHALAKSHMI 32Y F 32.6 3 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
40  FATHIMA BEEVI 40Y F 33.5 3.7 ABDOMINAL HYSTERCECTOMY P NO NO 5 DAYS NO NO NO NO
41  NITHYA 25Y F 32.8 3.2 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
42 ESWARAMOORTHY 44Y M 32.7 3.1 GASTRECTOMY A NO NO 7 DAYS NO NO NO NO
43 NAYANAR 53Y M 36.1 4.2 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
44 JAMUNA 31Y  F 32.6 3.1 INCISIONAL HERNIA REPAIR A NO NO 5 DAYS NO NO NO NO
45 DEVAN 40Y M 32.7 3.4 NISSEN'S FUNDOPLICATION P NO NO 6 DAYS NO NO NO NO
46  BANUMATHY 29Y F 36.5 4.5 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
47 VASANTHI 45Y F 34.7 3.8 PANCREATICOJEJUNOSTOMY P NO NO 7 DAYS NO NO NO NO
48 KABIR NISHA 47Y F 36.8 4.8 ABDOMINAL HYSTERCECTOMY P NO NO 5 DAYS NO NO NO NO
49 RAVI KUMAR 34Y M 34.2 3.9 CYSTOGASTROSTOMY A YES YES 18 DAYS YES NO YES NO
50 PRAVEEN KUMAR 28Y M 32.3 3.2 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
51 KAVI PRABHA 32Y F 33.7 3.1 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
52 PRASHANTH 37Y  M 36.8 4.7 VAGOTOMY WITH GJ P NO NO 8 DAYS NO NO NO NO
53  JOTHINARAYANASAMY 34Y M 32.5 3.1 CYSTOJEJUNOSTOMY P NO NO 6 DAYS NO NO NO NO
54 MUKHESH 32Y M 35.7 3.7 PANCREATICOJEJUNOSTOMY A YES YES 21 DAYS YES NO YES NO
55 LOGESH 26Y M 35.9 3.9 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
56 DHANALAKSHMI 41Y F 34.2 3.5 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
57 KUMARI 36Y F 35.7 3.6 INCISIONAL HERNIA REPAIR A YES YES 20 DAYS YES NO YES NO
58 KAVIN PRABHU 22Y M 36.7 3.7 NISSEN'S FUNDOPLICATION P NO NO 5 DAYS NO NO NO NO
59 PRIYADHARSHINI 27Y F 34.2 3 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
60 GAYATHRI 25Y F 33.7 3 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
61  VASANTH 29Y M 32.7 3 WHIPPLE'S PROCEDURE P NO NO 7 DAYS NO NO NO NO
62 DAMODHARAN 40Y M 34.7 3.4 GASTRECTOMY A NO NO 7 DAYS NO NO NO NO
63  YUKESH 30Y M 32.1 3.5 CYSTOJEJUNOSTOMY P NO NO 7 DAYS NO NO NO NO
64 PARVATHI 47Y F 32.4 3.2 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
65 YASODHA 35Y F 36.8 4.7 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
66 RAMESH 33Y M 37.4 5.2 NISSEN'S FUNDOPLICATION P NO NO 6 DAYS NO NO NO NO
 
 
 
 
 
 
 
 
 
  
67 RAJA KUMAR 31Y M 32.2 3 WHIPPLE'S PROCEDURE P NO NO 8 DAYS NO NO NO NO
68 FRANCIS MATHEW 36Y M 34.2 3.5 LEFT HEMICOLECTOMY A YES YES 19 DAYS NO NO YES YES
69 LAKSHMI 51Y F 36.1 4.3 ABDOMINAL HYSTERCECTOMY A NO NO 5 DAYS NO NO NO NO
70 RAHMATH NISHA 48Y F 32.6 3.2 INCISIONAL HERNIA REPAIR A NO NO 5 DAYS NO NO NO NO
71 BOOPATHY RAJA 39Y M 34.2 3.4 CHOLECYSTECTOMY A YES YES 13 DAYS NO NO YES YES
72 SELVARAJ 47Y M 32.2 3 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
73 ANGELLA 41Y F 38.4 5.2 CHOLECYSTECTOMY P YES NO 6 DAYS NO NO NO YES
74 LOGESHWARAN 46Y M 34.1 3.4 INCISIONAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
75  ASARAF ALI 41Y M 32.8 3 CYSTOGASTROSTOMY A NO NO 6 DAYS NO NO NO NO
76 AMSA NANDHINI 24Y F 32.4 3 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
77 HARISH KUMAR 31Y M 32.8 3.2 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
78 BALAKRISHNAN 59Y M 36.4 4.1 RIGHT HEMICOLECTOMY P NO NO 6 DAYS NO NO NO NO
79 NIRMALA 50Y F 34.2 3.6 INCISIONAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
80 RAJESH KUMAR 42Y M 32.2 3 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
81 NAGAPPAN 52Y M 37.4 5 GASTRECTOMY P NO NO 7 DAYS NO NO NO NO
82 RATHINAM 55Y F 32.5 3.1 CHOLECYSTECTOMY A YES YES 12 DAYS NO NO YES NO
83 KABHIR MOHAMMED 42Y M 36.4 4.1 LEFT HEMICOLECTOMY P NO NO 7 DAYS NO NO NO NO
84 BHARATHI 38Y F 32.4 3.2 INCISIONAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
85 KUMARALINGAM 46Y M 37.6 4.8 VAGOTOMY WITH GJ P NO NO 7 DAYS NO NO NO NO
86 PRATEIK 31Y M 32.4 3.1 PANCREATICOJEJUNOSTOMY A YES YES 24 DAYS NO NO YES NO
87 FARZANA 24Y F 34.2 3.2 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
88 HUSSAIN 41Y M 32.4 3.3 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
89 GOWTHAM 31Y M 36.4 4.3 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
90  MANI 42Y M 34.7 3.5 GASTRECTOMY P NO NO 6 DAYS NO NO NO NO
91 MURUGALAKSHMI 34Y F 32.6 3 NISSEN'S FUNDOPLICATION A NO NO 6 DAYS NO NO NO NO
92 PRASANA 32Y M 32.8 3 GASTRECTOMY A NO NO 7 DAYS NO NO NO NO
93 SUJATHA 50Y F 36.7 4.8 RIGHT HEMICOLECTOMY P NO NO 6 DAYS NO NO NO NO
94 PREETHI 24Y F 32.4 3.1 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
95 MANOJ 27Y M 34.6 3.6 INCISIONAL HERNIA REPAIR A YES YES 17 DAYS YES NO NO NO
96 PRANAV 26Y M 38.5 4.5 PANCREATICOJEJUNOSTOMY P NO NO 7 DAYS NO NO NO NO
97 ROHIT 27Y M 32.7 3 CYSTOGASTROSTOMY A NO NO 6 DAYS NO NO NO NO
98 VARGHEESE BABU 34Y M 33.6 3.3 NISSEN'S FUNDOPLICATION P NO NO 7 DAYS NO NO NO NO
99 SUNDARAM 52Y M 37.2 4.2 GASTRECTOMY P NO NO 8 DAYS NO NO NO NO
100 CHANDRA 51Y F 36.4 3.9 CHOLECYSTECTOMY A YES YES 16 DAYS NO NO YES YES
101 MARAGATHAM 52Y F 34.1 3.5 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
102 PRABHAKARAN 47Y M 35.2 3.8 RIGHT HEMICOLECTOMY A YES YES 21 DAYS YES NO NO YES
103 PARAMESHWARI 43Y F 32.9 3 INCISIONAL HERNIA REPAIR A NO NO 5 DAYS NO NO NO NO
104 NANDHA KUMAR 45Y M 34.9 3.6 VAGOTOMY WITH GJ P NO NO 6 DAYS NO NO NO NO
105 MURUGANANDAN 34Y M 34.4 3.2 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
106  PARAMESH 39Y M 34.4 3.4 CYSTOJEJUNOSTOMY P NO NO 5 DAYS NO NO NO NO
107 SHALINI 26Y F 32.6 3 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
108 DIVAKAR 31Y M 32.4 3 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
109 LOGANATHAN 53Y M 35.6 4.1 CHOLECYSTECTOMY P YES YES 7 DAYS NO NO NO YES
110 SAKTHIVEL 36Y M 34.2 3.2 INCISIONAL HERNIA REPAIR A NO NO 5 DAYS NO NO NO NO
111 PRAGADEESH 31Y M 32.2 3 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
112 MAHALAKSHMI 36Y F 37.4 5.2 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
113 SUNDARAMBAL 54Y F 38.5 5.6 GASTRECTOMY P YES YES 14 DAYS NO NO NO YES
114 HARSHINI 24Y F 32.5 3 PARAUMBILICAL HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
115 KAMAL RAJ 27Y M 34.5 3.4 CYSTOGASTROSTOMY A YES YES 20 DAYS NO NO YES YES
116 PREM KUMAR 56Y M 32.8 3.2 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
117  VIMAL RAJ 32Y M 33.5 3.7 RIGHT HEMICOLECTOMY P NO NO 7 DAYS NO NO NO NO
118 GOVINDHAN 41Y M 34.7 3.9 PANCREATICOJEJUNOSTOMY P NO NO 8 DAYS NO NO NO NO
119 SATHYAPRAKASH 37Y M 32.2 3 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
120 VIKASHINI 25Y F 34.7 3.4 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
121 SWATHI RANI 35Y F 32.6 3 INCISIONAL HERNIA REPAIR A NO NO 4 DAYS NO NO NO NO
122 ESWARAN 51Y M 34.1 3.9 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
123 VIDHYA 32Y F 36.2 4.2 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
124 MUNIYAMMAL 53Y F 37.8 4.6 VAGOTOMY WITH GJ P NO NO 7 DAYS NO NO NO NO
125 LAKSHMANAN 41Y M 34.9 3.6 GASTRECTOMY A YES YES 25 DAYS NO YES NO NO
126 PADMANATHAN 39Y M 36.3 4.4 CHOLECYSTECTOMY A YES YES 11 DAYS NO YES NO YES
127 AMUTHA 41Y F 38.7 5.7 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
128 SEETHA 49Y F 32.5 3 CHOLECYSTECTOMY A NO NO 3 DAYS NO NO NO NO
129 RASATHI 45Y F 34.7 3.5 ABDOMINAL HYSTERCECTOMY P NO NO 5 DAYS NO NO NO NO
130 BALAMURUGAN 41Y M 32.6 3 NISSEN'S FUNDOPLICATION A NO NO 6 DAYS NO NO NO NO
131 HARESH 36Y M 37.7 5.3 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
132 JOSEPH 42Y M 33.8 3.4 CHOLECYSTECTOMY A YES YES 11 DAYS NO YES NO YES
133 SINDHU 28Y F 34.2 3.9 PARAUMBILICAL HERNIA REPAIR A YES YES 16 DAYS NO YES NO YES
134 SAMARAJ 58Y M 36.2 4.7 GASTRECTOMY P NO NO 6 DAYS NO NO NO NO
135 PRABHU 31Y M 32.5 3 EPIGASTRIC HERNIA REPAIR A NO NO 3 DAYS NO NO NO NO
 
 
 
 
 
 
 
 
 
 
  
136 MALINI 39Y F 36.4 3.8 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
137 MALATHI 46Y F 32.2 3 VAGOTOMY WITH GJ A NO NO 7 DAYS NO NO NO NO
138  JAGADEESH 45Y M 36.5 4.1 CYSTOGASTROSTOMY P NO NO 5 DAYS NO NO NO NO
139 KUPPANAN 52Y M 34.8 3.5 LEFT HEMICOLECTOMY A NO NO 7 DAYS NO NO NO NO
140  NALINI 35Y F 32.5 3 INCISIONAL HERNIA REPAIR P NO NO 4 DAYS NO NO NO NO
141 RAJAPPA 55Y M 36.7 4.5 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
142 KAVYA 39Y F 35.5 4.1 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
143 DHAYALAN 27Y M 36.7 4.8 EPIGASTRIC HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
144 MUKILAN 35Y M 34.9 3.9 EPIGASTRIC HERNIA REPAIR A YES YES 19 DAYS YES NO NO YES
145 NITHESH 26Y M 32.8 3 INCISIONAL HERNIA REPAIR A NO NO 6 DAYS NO NO NO NO
146 FATHIMA BEEVI 46Y F 36.4 4.8 ABDOMINAL HYSTERCECTOMY P NO NO 7 DAYS NO NO NO NO
147 MOHIDEEN 31Y M 33.9 3.2 INCISIONAL HERNIA REPAIR A YES YES 18 DAYS NO YES NO YES
148 AJAY 37Y M 34.7 3.7 PARAUMBILICAL HERNIA REPAIR P NO NO 3 DAYS NO NO NO NO
149 BHAGYALAKSHMI 46Y F 32.5 3 CHOLECYSTECTOMY A YES YES 19 DAYS YES NO NO YES
150 KUMARSAMY 51Y M 34.5 3.8 CHOLECYSTECTOMY P NO NO 3 DAYS NO NO NO NO
P - PRESENT THAT IS SUBCUTANEOUS DRAIN KEPT
A - ABSENT THAT IS SUBCUTANEOUS DRAIN NOT KEPT
6 PATIENTS WITH SUBCUTANEOUS DRAIN HAS COMPLICATIONS ( 4 - PAIN AT THE DRAIN SITE, 2 -SURGICAL SITE INFECTIONS )
25 PATIENTS WITHOUT SUBCUTANEOUS DRAIN HAS COMPLICATIONS ( 14 - SEROMA, 5 - HAEMATOMA, 11 - SURGICAL SITE INFECTION, 11 - PAIN AT THE SITE OF WOUND )
 
 
 
 
 
